Orphan designation: Lisocabtagene maraleucel, Treatment of primary mediastinal large B-cell lymphoma, 19/11/2018, Positive

SEMrush
Orphan designation: Lisocabtagene maraleucel, Treatment of primary mediastinal large B-cell lymphoma, 19/11/2018, Positive
[automaticbacklinks]